Literature DB >> 7840566

Effect of lactation on single-dose pharmacokinetics of norfloxacin nicotinate in ewes.

S Soback1, M Gips, M Bialer, A Bor.   

Abstract

In a three-way crossover trial, six healthy Finnish-Merino-Awassi ewes were given a single intravenous injection of norfloxacin nicotinate (in a dose equivalent to 25 mg of norfloxacin base per kg of body weight) during nursing, 1 day after weaning, and 1 month after weaning. Blood and milk samples were collected at different time intervals following dosing, and norfloxacin concentrations were determined by a high-performance liquid chromatography assay. The serum drug concentration versus time data were analyzed by a noncompartmental approach which was based on the statistical-moment theory. The total body clearance values were 4.2 +/- 1.3 (injection during nursing), 1.6 +/- 0.3 (injection 1 day after weaning), and 3.1 +/- 0.8 ml/min/kg (injection 1 month after weaning). The mean residence times were 335 +/- 83, 797 +/- 129, and 481 +/- 102 min and terminal half-lives were 266 +/- 51, 603 +/- 94, and 372 +/- 68 min for the respective treatments. The estimated volumes of distribution at steady state were 1.3 +/- 0.1, 1.2 +/- 0.1, and 1.4 +/- 0.2 liter/kg for the respective treatments. Milk norfloxacin concentrations were up to 40 times higher than the corresponding concentrations in serum during lactation. Accordingly, in ewes with 1.5 liter of milk in the udder more than half of the drug in the animal appeared to be in the milk. Therapeutic concentrations of norfloxacin could be detected in the sera of suckling lambs, implicating that fluoroquinolone therapy should be discouraged during breast feeding. In lactating ewes and in ewes with full udders, moment analysis calculations did not show a significant difference between the system moment mean residence time and the system matrix mean residence time values. Thus, the pharmacokinetics of norfloxacin in the three groups could be described by the classical two-compartment open-body model with input and output occurring from the central compartment. The results did not support the existence of a distinguishable milk compartment. Milk secretion seemed to act as one of the clearance processes of the drug when milk was continuously removed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7840566      PMCID: PMC284740          DOI: 10.1128/AAC.38.10.2336

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  9 in total

1.  Benzylpenicillin kinetics in the ewe: influence of pregnancy and lactation.

Authors:  M Oukessou; S Benlamlih; P L Toutain
Journal:  Res Vet Sci       Date:  1990-09       Impact factor: 2.534

2.  Types of mean residence times.

Authors:  J G Wagner
Journal:  Biopharm Drug Dispos       Date:  1988 Jan-Feb       Impact factor: 1.627

3.  Prediction of drug distribution into human milk from physicochemical characteristics.

Authors:  H C Atkinson; E J Begg
Journal:  Clin Pharmacokinet       Date:  1990-02       Impact factor: 6.447

Review 4.  Pharmacokinetic pitfalls in the estimation of the breast milk/plasma ratio for drugs.

Authors:  J T Wilson; R D Brown; J L Hinson; J W Dailey
Journal:  Annu Rev Pharmacol Toxicol       Date:  1985       Impact factor: 13.820

5.  General treatment of mean residence time, clearance, and volume parameters in linear mammillary models with elimination from any compartment.

Authors:  E Nakashima; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1988-10

6.  Statistical moments in pharmacokinetics.

Authors:  K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharmacokinet Biopharm       Date:  1978-12

7.  Noncompartmental determination of the steady-state volume of distribution.

Authors:  L Z Benet; R L Galeazzi
Journal:  J Pharm Sci       Date:  1979-08       Impact factor: 3.534

Review 8.  Norfloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  B Holmes; R N Brogden; D M Richards
Journal:  Drugs       Date:  1985-12       Impact factor: 9.546

9.  Pharmacokinetics of the gyrase inhibitor marbofloxacin: influence of pregnancy and lactation in sows.

Authors:  K Petracca; J L Riond; T Graser; M Wanner
Journal:  Zentralbl Veterinarmed A       Date:  1993-02
  9 in total
  4 in total

1.  Some pharmacokinetic parameters of pefloxacin in lactating goats.

Authors:  A M Abd El-Aty; A Goudah
Journal:  Vet Res Commun       Date:  2002-10       Impact factor: 2.459

2.  Pharmacokinetics and milk penetration of ibafloxacin after intravenous administration to lactating goats.

Authors:  Pedro Marín; Carlos M Cárceles; Elisa Escudero; Emilio Fernández-Varón
Journal:  Can J Vet Res       Date:  2007-01       Impact factor: 1.310

3.  Pharmacokinetics of Tildipirosin in Plasma, Milk, and Somatic Cells Following Intravenous, Intramuscular, and Subcutaneous Administration in Dairy Goats.

Authors:  Juan Sebastián Galecio; Pedro Marín; Verónica Hernandis; María Botía; Elisa Escudero
Journal:  Pharmaceutics       Date:  2022-04-13       Impact factor: 6.525

Review 4.  Antibacterial Drug Residues in Small Ruminant Edible Tissues and Milk: A Literature Review of Commonly Used Medications in Small Ruminants.

Authors:  Emily D Richards; Krysta L Martin; Catherine E Donnell; Maaike O Clapham; Lisa A Tell
Journal:  Animals (Basel)       Date:  2022-09-28       Impact factor: 3.231

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.